Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SUGAMMADEX AMOMED 100 MG/ML DE SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SUGAMMADEX AMOMED 100 MG/ML DE SOLUCION INYECTABLE

Approved

STANDARD

SUGAMMADEX AMOMED 100 MG/ML DE SOLUCION INYECTABLE

Aop Orphan Pharmaceuticals Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 13, 2023
Approval ID: 98a1888d508f2df0
Company: Aop Orphan Pharmaceuticals Gmbh
Type: Standard

Approval Details

Approval Id: 98a1888d508f2df0
Drug Cima Aemps Name: SUGAMMADEX AMOMED 100 MG/ML DE SOLUCION INYECTABLE
Register Number: 1221708001
Holder Company Name: Aop Orphan Pharmaceuticals Gmbh
Marketing Company Name: Aop Orphan Pharmaceuticals Iberia, S.L.U
Holder Company Detail Path: /organization/aop-orphan-pharmaceuticals-gmbh
Authorization Date: 2023-04-13
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 100 MG/ML
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Aop Orphan Pharmaceuticals Gmbh
Company Detail Path: /organization/aop-orphan-pharmaceuticals-gmbh

Company Information

Pharmaceutical Company Name: AOP Orphan Pharmaceuticals GmbH
Country Name: Austria
City Name: wien,wien,country_at
Address: Leopold Ungar Platz 2
Website: http://www.aoporphan.com

Active Ingredients

SUGAMMADEX SODIO

217,6 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 13, 2023

Approval ID

98a1888d508f2df0

Type

Standard

Back to CIMA-AEMPS Approvals